secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001493152-24-009216
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros FY2023 revenue up 43% to $14.2M; net loss narrows to $1.6M from $4.3M
-----------------------------------------------------------------------------

- Full-year net revenue from continuing ops $14.2M, up 43% YoY; Q4 revenue $3.3M, up 27%.
- Net loss from continuing ops improved 63% to ($1.6M) for FY2023 vs ($4.3M) in 2022.
- Adjusted EBITDA loss from continuing ops narrowed to ($0.1M) for FY2023, an improvement of 97%.
- Cash and cash equivalents $4.3M at Dec 31, 2023; company remains debt-free.
- CEO cites regulatory tailwinds from new water safety standards like ASHRAE 514 driving growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315224009216/0001493152-24-009216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315224009216/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer